Search Results - "KANESVARAN, Ravindran"

Trajectories of physical symptom burden and psychological distress during the last year of life in patients with a solid metastatic cancer by Shafiq, Mahham, Malhotra, Rahul, Teo, Irene, Ozdemir, Semra, Kanesvaran, Ravindran, Malhotra, Chetna

“…Objective To delineate the trajectories of physical symptoms and psychological distress among patients with a solid metastatic cancer during the last year of…”
Get full text

Priorities for the global advancement of care for older adults with cancer: an update of the International Society of Geriatric Oncology Priorities Initiative by Extermann, Martine, Brain, Etienne, Canin, Beverly, Cherian, Meena Nathan, Cheung, Kwok-Leung, de Glas, Nienke, Devi, Beena, Hamaker, Marije, Kanesvaran, Ravindran, Karnakis, Theodora, Kenis, Cindy, Musolino, Najia, O'Donovan, Anita, Soto-Perez-de-Celis, Enrique, Steer, Christopher, Wildiers, Hans

“…In 2011, the International Society of Geriatric Oncology (SIOG) published the SIOG 10 Priorities Initiative, which defined top priorities for the improvement…”
Get full text

Experiences with health care practitioners among advanced cancer patients and their family caregivers: A longitudinal dyadic study by Malhotra, Chetna, Chaudhry, Isha, Ozdemir, Semra, Teo, Irene, Kanesvaran, Ravindran

“…Background Assessing patient and caregiver experiences with care is central to improving care quality. The authors assessed variations in the experiences of…”
Get full text

Analysis of Prognostic Factors of Comprehensive Geriatric Assessment and Development of a Clinical Scoring System in Elderly Asian Patients With Cancer by KANESVARAN, Ravindran, HUIHUA LI, KOO, Khai-Nee, POON, Donald

“…To determine the impact of each comprehensive geriatric assessment (CGA) domain on overall survival (OS) and develop a prognostic scoring system for elderly…”
Get full text

Elderly patients with metastatic renal cell carcinoma: position paper from the International Society of Geriatric Oncology by Kanesvaran, Ravindran, Saux, Olivia Le, Motzer, Robert, Choueiri, Toni K, Scotté, Florian, Bellmunt, Joaquim, Launay-Vacher, Vincent

“…Therapy for metastatic renal cell carcinoma should be tailored to the circumstances and preferences of the individual patient. Age should not be a barrier to…”
Get full text

The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study by Ko, Jenny J, MD, Xie, Wanling, MS, Kroeger, Nils, MD, Lee, Jae-lyun, MD, Rini, Brian I, MD, Knox, Jennifer J, MD, Bjarnason, Georg A, MD, Srinivas, Sandy, MD, Pal, Sumanta K, MD, Yuasa, Takeshi, MD, Smoragiewicz, Martin, MD, Donskov, Frede, MD, Kanesvaran, Ravindran, MD, Wood, Lori, MD, Ernst, D Scott, MD, Agarwal, Neeraj, MD, Vaishampayan, Ulka N, MD, Rha, Sun-young, MD, Choueiri, Toni K, MD, Heng, Daniel Y C, Dr

“…Summary Background Previous prognostic models for second-line systemic therapy in patients with metastatic renal cell carcinoma have not been studied in the…”
Get full text

Mentoring stages: A study of undergraduate mentoring in palliative medicine in Singapore by Krishna, Lalit, Toh, Ying Pin, Mason, Stephen, Kanesvaran, Ravindran

“…Mentoring nurtures a mentee's personal and professional development. Yet conflation of mentoring approaches and a failure to contend with mentoring's nature…”
Get full text

Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival by Dudani, Shaan, de Velasco, Guillermo, Wells, J Connor, Gan, Chun Loo, Donskov, Frede, Porta, Camillo, Fraccon, Anna, Pasini, Felice, Lee, Jae Lyun, Hansen, Aaron, Bjarnason, Georg A, Beuselinck, Benoit, Pal, Sumanta K, Yuasa, Takeshi, Kroeger, Nils, Kanesvaran, Ravindran, Reaume, M Neil, Canil, Christina, Choueiri, Toni K, Heng, Daniel Y C

“…There exists considerable biological and clinical variability between histologic variants of metastatic renal cell carcinoma (mRCC). Data reporting on patterns…”
Get full text

Is Genetic testing coming of age in advanced prostate cancer? by Chen, Kenneth, Ong, Sean, Vasundhara, Kandarpa, Mun, Chow Kit, Williams, Isabella, Kanesvaran, Ravindran, Peng, John Yuen Shyi, Azad, Arun, Lawrentschuk, Nathan

Get full text

Assessing mentoring: A scoping review of mentoring assessment tools in internal medicine between 1990 and 2019 by Ng, Yong Xiang, Koh, Zachary Yong Keat, Yap, Hong Wei, Tay, Kuang Teck, Tan, Xiu Hui, Ong, Yun Ting, Tan, Lorraine Hui En, Chin, Annelissa Mien Chew, Toh, Ying Pin, Shivananda, Sushma, Compton, Scott, Mason, Stephen, Kanesvaran, Ravindran, Krishna, Lalit

“…Mentoring's success in enhancing a mentee's professional and personal development, and a host organisations' reputation has been called into question, amidst a…”
Get full text

Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis by Tan, Aaron C., Lai, Gillianne G.Y., Tan, Gek San, Poon, Shou Yu, Doble, Brett, Lim, Tse Hui, Aung, Zaw Win, Takano, Angela, Tan, Wan Ling, Ang, Mei-Kim, Tan, Bien Soo, Devanand, Anantham, Too, Chow Wei, Gogna, Apoorva, Ong, Boon-Hean, Koh, Tina P.T., Kanesvaran, Ravindran, Ng, Quan Sing, Jain, Amit, Rajasekaran, Tanujaa, Lim, Alvin S.T., Lim, Wan Teck, Toh, Chee Keong, Tan, Eng-Huat, Lim, Tony Kiat Hon, Tan, Daniel S.W.

“…•Upfront NGS is feasible and cost-effective in an EGFR mutant predominant population.•Characterizing the wider genomic profile may yield important…”
Get full text

Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium by Yip, Steven M., Wells, Connor, Moreira, Raphael, Wong, Alex, Srinivas, Sandy, Beuselinck, Benoit, Porta, Camillo, Sim, Hao‐Wen, Ernst, D. Scott, Rini, Brian I., Yuasa, Takeshi, Basappa, Naveen S., Kanesvaran, Ravindran, Wood, Lori A., Canil, Christina, Kapoor, Anil, Fu, Simon Y.F., Choueiri, Toni K., Heng, Daniel Y.C.

“…BACKGROUND To the authors' knowledge, outcomes and prognostic tools have yet to be clearly defined in patients with metastatic renal cell carcinoma (mRCC) who…”
Get full text

Hope, bias and survival expectations of advanced cancer patients: A cross‐sectional study by Finkelstein, Eric A., Baid, Drishti, Cheung, Yin Bun, Schweitzer, Maurice E., Malhotra, Chetna, Volpp, Kevin, Kanesvaran, Ravindran, Lee, Lai Heng, Dent, Rebecca Alexandra, Ng Chau Hsien, Matthew, Bin Harunal Rashid, Mohamad Farid, Somasundaram, Nagavali

“…Objective Many patients with advanced illness are unrealistically optimistic about their prognosis. We test for the presence of several cognitive biases,…”
Get full text

Efficacy and safety of therapies for advanced prostate cancer in Asia: Evidence from a systematic literature review by Saad, Marniza, Umbas, Rainy, Chiong, Edmund, Kanesvaran, Ravindran

“…Objectives: Several therapies are available for the treatment of advanced/metastatic prostate cancer (PC). However, the systematic assessment of evidence…”
Get full text

EGFR Mutation Subtypes Influence Survival Outcomes following First-Line Gefitinib Therapy in Advanced Asian NSCLC Patients by Sutiman, Natalia, Tan, Shao Weng, Tan, Eng Huat, Lim, Wan Teck, Kanesvaran, Ravindran, Ng, Quan Sing, Jain, Amit, Ang, Mei Kim, Tan, Wan Ling, Toh, Chee Keong, Chowbay, Balram

“…Activating mutations in the EGFR gene have been shown to confer sensitivity to EGFR tyrosine kinase inhibitors in patients with advanced NSCLC. However, wide…”
Get more information

Androgen receptor pathway inhibitors, prostate cancer, and older adults: a global Young International Society of Geriatric Oncology drug review by Mir, Nabiel, Burke, Olivia, Yates, Samuel, Rajasekaran, Tanujaa, Chan, Johan, Szmulewitz, Russell, Kanesvaran, Ravindran

“…Prostate cancer is a disease of older adults that has undergone a significant therapeutic paradigm shift in the last decade with the emergence of novel…”
Get full text

Quality of life of elderly patients with solid tumours undergoing adjuvant cancer therapy: a systematic review by Cheng, Karis Kin-Fong, Lim, Ethel Yee-Ting, Kanesvaran, Ravindran

“…ObjectivesThe measurement of quality of life (QoL) in elderly cancer population is increasingly being recognised as an important element of clinical…”
Get full text

Clinical features and response to immune combinations in patients with renal cell carcinoma and sarcomatoid de-differentiation (ARON-1 study) by Ciccarese, Chiara, Büttner, Thomas, Cerbone, Linda, Zampiva, Ilaria, Monteiro, Fernando Sabino M, Basso, Umberto, Pichler, Martin, Vitale, Maria Giuseppa, Fiala, Ondrej, Roviello, Giandomenico, Kopp, Ray Manneh, Carrozza, Francesco, Pichler, Renate, Grillone, Francesco, Calabuig, Esther Pérez, Zeppellini, Annalisa, Küronya, Zsófia, Galli, Luca, Facchini, Gaetano, Sunela, Kaisa, Mosca, Alessandra, Molina-Cerrillo, Javier, Spinelli, Gian Paolo, Ansari, Jawaher, Scala, Alessandro, Mollica, Veronica, Grande, Enrique, Buti, Sebastiano, Kanesvaran, Ravindran, Zakopoulou, Roubini, Bamias, Aristotelis, Rizzo, Mimma, Massari, Francesco, Iacovelli, Roberto, Santoni, Matteo

“…Metastatic renal cell carcinoma (mRCC) carrying sarcomatoid features (sRCC) has aggressive biology and poor prognosis. First-line immunotherapy (IO)-based…”
Get full text

Detection of circulating tumor DNA with ultradeep sequencing of plasma cell‐free DNA for monitoring minimal residual disease and early detection of recurrence in early‐stage lung cancer by Tan, Aaron C., Lai, Gillianne G. Y., Saw, Stephanie P. L., Chua, Kevin L. M., Takano, Angela, Ong, Boon‐Hean, Koh, Tina P. T., Jain, Amit, Tan, Wan Ling, Ng, Quan Sing, Kanesvaran, Ravindran, Rajasekaran, Tanujaa, Kalashnikova, Ekaterina, Renner, Derrick, Sudhaman, Sumedha, Malhotra, Meenakshi, Sethi, Himanshu, Liu, Minetta C., Aleshin, Alexey, Lim, Wan‐Teck, Tan, Eng‐Huat, Skanderup, Anders J., Ang, Mei‐Kim, Tan, Daniel S. W.

“…Background In early‐stage non–small cell lung cancer (NSCLC), recurrence is frequently observed. Circulating tumor DNA (ctDNA) has emerged as a noninvasive…”
Get full text

Risk stratification and management of non‐muscle‐invasive bladder cancer: A physician survey in six Asia‐Pacific territories by Ku, Ja Hyeon, Lee, Lui Shiong, Lin, Tzu‐Ping, Kikuchi, Eiji, Kitamura, Hiroshi, Ng, Chi‐Fai, Ng, Junice Yi Siu, Poon, Darren Ming‐Chun, Kanesvaran, Ravindran, Seo, Ho Kyung, Spiteri, Carmel, Tan, Ee Min, Tran, Ben, Tsai, Yuh‐Shyan, Nishiyama, Hiroyuki

“…Objectives Multiple clinical practice guidelines, conflicting evidence, and physician perceptions result in variations in risk stratification among patients…”
Get full text